Catch up on the latest news, updates, and stories from our community and beyond. From important announcements to behind-the-scenes highlights, there’s always something new to explore. Scroll down to read the latest posts and see what we've been up to.
A new clinical trial led by Professor Thomas Powles at Barts Cancer Institute, Queen Mary University of London, has shown that a blood test to detect tumour DNA could help doctors decide which patients with bladder cancer are most likely to benefit from further treatment after surgery. The new approach improved survival in those identified as high-risk while safely sparing low-risk patients from unnecessary side effects.
Conferences 22 October 2025
Prof Tom Powles and Prof Peter Schmid announced practice-changing results at ESMO 2024
Conferences 16 September 2024
Professor Tom Powles and team reveal first successful adjuvant therapy for kidney cancer in 50 years.
Conferences 19 April 2024
Experts in the field converged to discuss the latest advances in pancreatic cancer
Conferences 27 February 2024
Clinical trial results from BCI and Barts NHS trust provide new hope for people with bladder cancer.
Conferences 25 October 2023
Experts in the field converged to discuss the latest advances in pancreatic cancer
Conferences 29 June 2023
An innovative therapy provides new hope to patients with malignant mesothelioma – a rare but rapidly fatal type of cancer with few effective treatment options – according to results presented by Professor Peter Szlosarek and his team at Barts Cancer Institute, Queen Mary University of London.
Conferences 16 April 2023
Research conducted at Barts Cancer Institute (BCI), Queen Mary University of London, indicates that regular blood tests before and during chemotherapy for prostate cancer can detect whether or not a patient is resistant or developing resistance to treatment with a drug called docetaxel.
Conferences 11 November 2021
A new type of drug that helps target chemotherapy directly to cancer cells has been found to significantly increase survival of patients with the most common form of bladder cancer, according to results from a phase III clinical trial led in the UK by Professor Tom Powles from Barts Cancer Institute, Queen Mary University of London and Barts Health NHS Trust.
Conferences 15 February 2021
On 11th September 2020, Professors Hemant Kocher and Nick Lemoine hosted the eighth London Pancreas Workshop (LPW) - a forum for state-of-the-art clinical and basic research in pancreatic cancer. In a first for the biennial event, this year’s LPW took place online with pre-recorded speaker presentations and live, interactive Q&A sessions.
Conferences 30 September 2020
An immunotherapy drug called ‘avelumab’ has been shown to significantly improve survival in patients with the most common type of bladder cancer, according to results from a phase III clinical trial led by Professor Tom Powles.
Conferences 29 May 2020
Professor Ranjit Manchanda delivered the Shyam Agarwal Memorial Oration at the Indian Society of Cancer Genetics Conference on 15 December.
Conferences 16 December 2019
Once again this December, researchers from Barts Cancer Institute (BCI)’s Centre for Haemato-Oncology made the trip to the American Society of Hematology Annual Meeting and Exposition, which this year took place in Orlando, Florida.
Conferences 16 December 2019
The Queen Mary University of London professor leading an international breast cancer study says anastrozole – rather than tamoxifen – should be the preventive drug-of-choice for post-menopausal women at increased risk of developing the disease.
Conferences 12 December 2019
Results of an interim analysis from the KEYNOTE-522 trial have shown a treatment combination of immunotherapy plus chemotherapy to improve response rates in patients with early triple-negative breast cancer. Prof Peter Schmid presented the results at the ESMO Congress 2019 in Barcelona, Spain.
Conferences 30 September 2019
Professor Fran Balkwill was selected as a high-level delegation to the World Economic Forum in Dalian, China, to discuss her work in cancer research. As one of three researchers selected by the European Research Council to attend, she participated in presentations, panel discussions and press conferences on the topic of ‘Tackling cancer from within – new perspectives’.
Conferences 8 July 2019
Professor Peter Schmid, Lead of the Centre for Experimental Cancer Medicine at the Barts Cancer Institute, Queen Mary University of London, attended this year’s ASCO Annual Meeting and today presented updated survival data from the IMpassion130 trial.
Conferences 4 June 2019
Researchers from our Centre for Haemato-Oncology attended the 60th American Society of Hematology (ASH) Annual Meeting and Exposition to showcase our blood cancer research.
Conferences 14 January 2019